SCA is now the majority shareholder of Vinda, which is the third largest tissue company in China. China is the second largest tissue market globally.
“It is positive that we are now the majority shareholder of Vinda. We see the potential to further strengthen the company. Vinda is a well-known and well-managed company in the fast-growing Chinese market,” says Jan Johansson, president and CEO of SCA.
“Since its beginnings back in 1985, Vinda has grown and captured market shares in the tissue segment. SCA aims to develop collaboration with Vinda and utilize its extensive and robust distribution network,” says Johansson.
SCA will consolidate Vinda as of the first quarter of 2014.